Sermaglutide Inter...

Sermaglutide  Intermediates: tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu

Sermaglutide Intermediates: tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu

Min.Order / FOB Price:Get Latest Price

0 Metric Ton

Negotiable

  • Min.Order :0 Metric Ton
  • Purity: 99% up by HPLC
  • Payment Terms : L/C,D/A,D/P,T/T,

Keywords

tBuO-Ste-Glu(AEEA-AEEA-OH)-OtBu Sermaglutide intermediate 1118767-16-0

Quick Details

  • Appearance:White powder
  • Application:For the production of Sermaglutide API . For the treatment of diabetes and it can help to lose weight.
  • PackAge:1kg/foil bag; 25kg/drum
  • ProductionCapacity:500|Kilogram|Year
  • Storage:Stored in cool & dry place ,Kept away from strong light and heat
  • Transportation:

Superiority:

Sinoway advantages:

1) Specialized in pharmaceutical raw materials (API & Intermediates) over 35 years since 1987.

2) ISO 9001:2015 & SGS audited supplier . 

3) Accept various payment terms : T.T 30-60 days and L/C at sight.

4) We can do different terms of FOB ,CIF/CIP ,DDU, DDP ..

5) We have professional R&D team, technical team and logistic team.

Product advantages:

Using advanced recombinant protease with Bio-enzyme technology to produce the intermediates of Sermaglutide ( main chain and side chain).

Details:

API: Sermaglutide, CAS No.: 910463-68-2

       ( *Still in patent, so only for R&D use )

Sermaglutide Intermediates (Lyophilized powder) :

1) main chain (CAS No:1169630-82-3)

2) side chain (CAS No: 1118767-16-0)

tBuO-Ste-Glu(AEEA-AEEA-OH)OtBu

Usage: 

For the treatment of diabetes and it can help to lose weight.

Advantages:

1) Our Sermaglutide API is in Pilot stage with production quantity 100g per batch.

2) We will get DMF documents in early 2023, and submit to FDA in the middle of 2023 for Sermaglutide API.

3) Our sermaglutide API and intermediates are produced in GMP condition workshop, with high purity 99% up, single impurity below 0.1% by HPLC.

4) Competitive price compares with the original Novo Nordisk for API.

5) Sermaglutide is a very new and good API for diabetes with very large market demand quantities.

6) Using advanced recombinant protease with Bio-enzyme technology to produce the intermediates of Sermaglutide (main chain and side chain).

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View